Catalog Number: 4LSC2844
CAS #: N/A
Related CAS #: 936563-96-1 (unlabeled)
Name: [D5]-Ibrutinib; (R)-1-(3-(4-amino-3-(4-(phenoxy-d5)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)but-3-en-1-one
Ibrutinib is a Bruton tyrosine kinase (BTK) inhibitor used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL)/small lymphocityc lymphoma (SLL) and Waldenström’s macroglobulinemia, a form of non-Hodgkin’s lymphoma. Stable isotope labeled Ibrutinib is intended for use as an internal standard for the quantification of Ibrutinib by LC or GC-mass spectrometry.
If the number, nature and/or location of stable isotope label atoms (D, 15N, 13C) in this molecule don’t fit with your application, don’t hesitate to contact us to discuss your specific needs.
Stable isotope labeled active pharmaceutical ingredient (API), stable isotope dilution analysis, internal standard, stable isotope labeled standard (SIL), therapeutic drug monitoring (TDM), quantitative bioanalytical method validation, clinical diagnosis, LC/MS method validation, quantitative proteomics, selective reaction monitoring (SRM), multiple reaction monitoring (MRM), peptide based quantitative proteomics, custom stable isotope labeled (SIL) peptide, diagnostic breath test, clinical chemistry, diagnostic tools & biomarkers.
Enquiry about 4LSC2844 [D5]-Ibrutinib
We're ready to solve any rare chemicals sourcing or molecular design problem... Give us a shout ! Please fill out this form completely (incomplete form will not be considered).
If you don't find a product in our current offer, please don't hesitate to request a quote using our contact form.